Orphan Drug Designation (ODD)
-
US FDA grants orphan drug designation to Zydus Cadila’s Saroglitazar Mg
The drug is used for the treatment of patients with Primary Biliary Cholangitis (PBC), a liver disease Zydus Cadila said…
Read More » -
XNK Therapeutics receives US orphan drug status
The status was received for NK cell-based immunotherapy in multiple myeloma XNK Therapeutics has received Orphan Drug Designation (ODD) from…
Read More »
